Why the study?
Do ADP-induced platelet aggregation and platelet reactivity index VASP predict recurrent ischemic events in patients with NSTE ACS undergoing PCI?
Population
195 consecutive patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary…
Design
Cohort
Follow-up
30 days
Authors
Loading...
May support risk stratification for recurrent events post-PCI in NSTE-ACS; leaves open whether assay-guided therapy improves outcomes.
Do ADP-induced platelet aggregation and platelet reactivity index VASP predict recurrent ischemic events in patients with NSTE ACS undergoing PCI?
ADP-Ag ≥70% and PRI VASP >53% are useful markers to identify clopidogrel low responders at increased risk of recurrent ischemic events after PCI for NSTE ACS.
Frère et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: